Intravenous Infusions (XGHA:IIL) Interest Income: GHS0.00 Mil (TTM As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XGHA:IIL Intravenous Infusions Ltd XGHA:IIL
4 GF Score
Price GHS0.55
View Full Analysis

What is Intravenous Infusions Interest Income?

Intravenous Infusions XGHA:IIL +10.00% 4 Interest Income is GHS0.00 Mil as of . 20. GuruFocus rates XGHA:IIL with a GF Score™ of 4/100.

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments. Intravenous Infusions's interest income for the twelve months ended in . 20 was GHS0.00 Mil. Its interest income for the trailing twelve months (TTM) ended in . 20 was GHS0.00 Mil.

Intravenous Infusions Interest Income Historical Data

* Premium members only.

The historical data trend for Intravenous Infusions's Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Intravenous Infusions Interest Income Chart

Intravenous Infusions Annual Data
Trend
Interest Income

Intravenous Infusions Semi-Annual Data
Interest Income
XGHA:IIL
4GF Score
Intravenous Infusions Ltd XGHA:IIL
Interest Income is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Intravenous Infusions Interest Income Calculation

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Interest Income for the trailing twelve months (TTM) ended in . 20 was GHS0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Income →
What does a Interest Income of GHS0.00 Mil mean?
Intravenous Infusions (XGHA:IIL) has a Interest Income of GHS0.00 Mil as of . 20. Interest Income is the amount a company receives on savings accounts and certificates of deposits. View historical data on Intravenous Infusions and its competitors.
Is Intravenous Infusions' Interest Income too high?
Intravenous Infusions' current Interest Income is GHS0.00 Mil. Overall, Intravenous Infusions has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Intravenous Infusions' Interest Income compare to PTLF and PCYN?
Intravenous Infusions' Interest Income of GHS0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Income for a Drug Manufacturers company?
A good Interest Income depends on the Drug Manufacturers industry context. However, Interest Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Income mean?
A high Interest Income can signal that a stock is expensive relative to its fundamentals. Interest Income is the amount a company receives on savings accounts and certificates of deposits. View historical data on Intravenous Infusions and its competitors. Intravenous Infusions's current Interest Income is GHS0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Intravenous Infusions stock overvalued right now?
Intravenous Infusions (XGHA:IIL) has a current Interest Income of GHS0.00 Mil. The current Interest Income is GHS0.00 Mil. Intravenous Infusions' overall GF Score™ is 4/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Income calculated?
Interest Income is calculated from a company's financial statements. For Intravenous Infusions (XGHA:IIL), the current Interest Income is GHS0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Intravenous Infusions Business Description

Address Plot 4/7 Blk L, P.O Box KF 63, Effiduase-Koforidua, GHA
Intravenous Infusions Ltd engages in the production of intravenous infusion and small-volume injectables for therapeutic purposes. The product categories are IV fluids, giving sets, and small-volume injectables. The company earns a majority of its revenue from IV fluids. Some of the IV fluids are sodium chloride solutions, dextrose solutions, dextrose saline solutions, and dextran solutions. Small-volume injectables include pethidine injection, magnesium sulphate injection, and quinine injection. Giving sets include plain giving sets, and blood giving sets.
4GF Score

Get the complete analysis for XGHA:IIL

Interest Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

GHS0.55
Price